Pfizer's (PFE) Germano: Company Still in 'Evaluation Process' on Possible Split

Pfizer, Inc. (NYSE: PFE) Geno Germano said the company is still in "evaluation stage" on a breakup. Splitting commercial operations isn't hard, but dividing and reorganizing the supply chain is. The company will have more to say on a split-up later this year.

Geno Germano is President and General Manager, Specialty Care and Oncology at Pfizer. He is presenting at the Goldman Sachs 34th Annual Global Healthcare Conference this morning.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• General Fusion lists on Nasdaq via SPAC merger with $150M in cash
• Rapid Line sees stock surge with no known corporate cause
• Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency